169 related articles for article (PubMed ID: 11597385)
1. Angiogenic profile of childhood primitive neuroectodermal brain tumours/medulloblastomas.
Huber H; Eggert A; Janss AJ; Wiewrodt R; Zhao H; Sutton LN; Rorke LB; Phillips PC; Grotzer MA
Eur J Cancer; 2001 Nov; 37(16):2064-72. PubMed ID: 11597385
[TBL] [Abstract][Full Text] [Related]
2. MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma.
Grotzer MA; Hogarty MD; Janss AJ; Liu X; Zhao H; Eggert A; Sutton LN; Rorke LB; Brodeur GM; Phillips PC
Clin Cancer Res; 2001 Aug; 7(8):2425-33. PubMed ID: 11489822
[TBL] [Abstract][Full Text] [Related]
3. Loss of caspase-8 mRNA expression is common in childhood primitive neuroectodermal brain tumour/medulloblastoma.
Zuzak TJ; Steinhoff DF; Sutton LN; Phillips PC; Eggert A; Grotzer MA
Eur J Cancer; 2002 Jan; 38(1):83-91. PubMed ID: 11750844
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of endoglin (CD105) expression during childhood brain tumor-related angiogenesis. Anti-angiogenic therapy.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1998; 18(3A):1485-500. PubMed ID: 9673360
[TBL] [Abstract][Full Text] [Related]
5. High microvessel density in primitive neuroectodermal brain tumors of childhood.
Grotzer MA; Wiewrodt R; Janss AJ; Zhao H; Cnaan A; Sutton LN; Rorke LB; Phillips PC
Neuropediatrics; 2001 Apr; 32(2):75-9. PubMed ID: 11414647
[TBL] [Abstract][Full Text] [Related]
6. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas.
Eggert A; Ikegaki N; Kwiatkowski J; Zhao H; Brodeur GM; Himelstein BP
Clin Cancer Res; 2000 May; 6(5):1900-8. PubMed ID: 10815914
[TBL] [Abstract][Full Text] [Related]
7. Neurotrophin receptor TrkC predicts good clinical outcome in medulloblastoma and other primitive neuroectodermal brain tumors.
Grotzer MA; Janss AJ; Phillips PC; Trojanowski JQ
Klin Padiatr; 2000; 212(4):196-9. PubMed ID: 10994550
[TBL] [Abstract][Full Text] [Related]
8. TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors.
Grotzer MA; Janss AJ; Fung K; Biegel JA; Sutton LN; Rorke LB; Zhao H; Cnaan A; Phillips PC; Lee VM; Trojanowski JQ
J Clin Oncol; 2000 Mar; 18(5):1027-35. PubMed ID: 10694553
[TBL] [Abstract][Full Text] [Related]
9. Quantitative mRNA expression analysis of neurotrophin-receptor TrkC and oncogene c-MYC from formalin-fixed, paraffin-embedded primitive neuroectodermal tumor samples.
Kunz F; Shalaby T; Lang D; von Büren A; Hainfellner JA; Slavc I; Tabatabai G; Grotzer MA
Neuropathology; 2006 Oct; 26(5):393-9. PubMed ID: 17080715
[TBL] [Abstract][Full Text] [Related]
10. Telomere maintenance in childhood primitive neuroectodermal brain tumors.
Didiano D; Shalaby T; Lang D; Grotzer MA
Neuro Oncol; 2004 Jan; 6(1):1-8. PubMed ID: 14769133
[TBL] [Abstract][Full Text] [Related]
11. Expression of Apo-3 and Apo-3L in primitive neuroectodermal tumours of the central and peripheral nervous system.
Eggert A; Grotzer MA; Zuzak TJ; Ikegaki N; Zhao H; Brodeur GM
Eur J Cancer; 2002 Jan; 38(1):92-8. PubMed ID: 11750845
[TBL] [Abstract][Full Text] [Related]
12. Gene amplification in PNETs/medulloblastomas: mapping of a novel amplified gene within the MYCN amplicon.
Frühwald MC; O'Dorisio MS; Rush LJ; Reiter JL; Smiraglia DJ; Wenger G; Costello JF; White PS; Krahe R; Brodeur GM; Plass C
J Med Genet; 2000 Jul; 37(7):501-9. PubMed ID: 10882752
[TBL] [Abstract][Full Text] [Related]
13. PTEN and DMBT1 homozygous deletion and expression in medulloblastomas and supratentorial primitive neuroectodermal tumors.
Inda MM; Mercapide J; Muñoz J; Coullin P; Danglot G; Tuñon T; Martínez-Peñuela JM; Rivera JM; Burgos JJ; Bernheim A; Castresana JS
Oncol Rep; 2004 Dec; 12(6):1341-7. PubMed ID: 15547761
[TBL] [Abstract][Full Text] [Related]
14. Neurotrophins and Trk receptors in primitive neuroectodermal tumor cell lines.
Chiappa SA; Chin LS; Zurawel RH; Raffel C
Neurosurgery; 1999 Nov; 45(5):1148-54; discussion 1154-5. PubMed ID: 10549931
[TBL] [Abstract][Full Text] [Related]
15. Coexpression of platelet-derived growth factor alpha and beta receptors on medulloblastomas and other primitive neuroectodermal tumors is consistent with an immature stem cell and neuronal derivation.
Smits A; van Grieken D; Hartman M; Lendahl U; Funa K; Nistér M
Lab Invest; 1996 Jan; 74(1):188-98. PubMed ID: 8569181
[TBL] [Abstract][Full Text] [Related]
16. Placenta growth factor (PlGF) mRNA expression in brain tumors.
Nomura M; Yamagishi S; Harada S; Yamashima T; Yamashita J; Yamamoto H
J Neurooncol; 1998 Nov; 40(2):123-30. PubMed ID: 9892094
[TBL] [Abstract][Full Text] [Related]
17. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
18. Neurotrophin and neurotrophin receptor proteins in medulloblastomas and other primitive neuroectodermal tumors of the pediatric central nervous system.
Washiyama K; Muragaki Y; Rorke LB; Lee VM; Feinstein SC; Radeke MJ; Blumberg D; Kaplan DR; Trojanowski JQ
Am J Pathol; 1996 Mar; 148(3):929-40. PubMed ID: 8774147
[TBL] [Abstract][Full Text] [Related]
19. RASSF1A promoter is highly methylated in primitive neuroectodermal tumors of the central nervous system.
Inda MM; Castresana JS
Neuropathology; 2007 Aug; 27(4):341-6. PubMed ID: 17899687
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of SOX2, NOTCH1, and ID1 in supratentorial primitive neuroectodermal tumors: a distinct differentiation pattern from that of medulloblastomas.
Phi JH; Kim JH; Eun KM; Wang KC; Park KH; Choi SA; Kim YY; Park SH; Cho BK; Kim SK
J Neurosurg Pediatr; 2010 Jun; 5(6):608-14. PubMed ID: 20515335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
